Knowledge of both technique and biology supports meaningful conversations with your healthcare provider
13.1% weight loss at 12 weeks in phase 2 IcoSema / insulin icodec + semaglutide co-formulation for type 2 diabetes Delivery shift / Novo Nordisk is pursuing both oral and injectable next-gen options Timeline / oral semaglutide 50 mg and CagriSema regulatory submissions filed or expected 2025-2026 How Wegovy Works: The Mechanism Behind Semaglutide 2.4 mg Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the incretin hormone GLP-1 released by L-cells in the distal gut after eating
GLP-1 and GLP-1(936) are also cleaved by neutral endopeptidase (NEP24.11), yielding GLP-1(2836), a 9amino acid carboxy-terminal peptide with biological activity (11)
Okun The New England Journal of Medicines recent publication of a randomized study of a GLP-1 agonist originally designed for diabetes, but applied to Parkinson's disease, has led to a flurry of excitement and to a mountain of questions
As these brands prepare for a GLP-1 bowl all of their own, ADWEEK has rounded up the ads they are airing on Super Bowl Sunday
While Ozempic is approved by the U.S